Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesIn situ neoplasmsICD-10-CM d07-carcinoma-in-situ-genital-organs
    Ask Trek AI about this page

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Genital Organs: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D07 includes carcinoma in situ diagnoses of genital organs that are other or unspecified, covering noninvasive epithelial neoplasms of genital sites not categorized in more specific D07 subgroups. These ICD-10-CM diagnosis codes are used to document clinical encounters where noninvasive malignant cells are present without invasion, capturing disease location and extent for accurate clinical records. Accurate coding within the ICD-10-CM D07 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Genital Organs: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D07: Carcinoma In Situ Of Other And Unspecified Genital Organs Overview

    This diagnosis group represents carcinoma in situ lesions affecting genital organs not classified elsewhere, including unspecified or less common genital sites. These are noninvasive neoplasms confined to the epithelium of the affected genital organ. Accurate coding matters for clinical records and reimbursement because it distinguishes in situ disease from invasive malignancy and supports appropriate claim processing.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when pathology or clinical evaluation documents carcinoma in situ of a genital organ that is categorized as other or unspecified. These codes apply when the diagnosis explicitly indicates in situ disease without evidence of invasion or metastasis.

    ICD-10-CM Codes

    10 rows

    ICD-10-CM CodeDescription
    D07.0Carcinoma in situ of endometrium
    D07.1Carcinoma in situ of vulva
    D07.2Carcinoma in situ of vagina
    D07.30Carcinoma in situ of unspecified female genital organs
    D07.39Carcinoma in situ of other female genital organs
    D07.4Carcinoma in situ of penis
    D07.5Carcinoma in situ of prostate
    D07.60Carcinoma in situ of unspecified male genital organs
    D07.61Carcinoma in situ of scrotum
    D07.69Carcinoma in situ of other male genital organs

    DRG Codes

    14 rows

    DRG CodeDescription
    715Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC
    716Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC
    722Malignancy, Male Reproductive System with MCC
    723Malignancy, Male Reproductive System with CC
    724Malignancy, Male Reproductive System without CC/MCC
    736Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC
    737Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC
    738Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC
    739Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC
    740Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC
    741Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC
    754Malignancy, Female Reproductive System with MCC
    755Malignancy, Female Reproductive System with CC
    756Malignancy, Female Reproductive System without CC/MCC

    Typical Clinical Scenarios

    • An asymptomatic middle-aged woman presents for routine pelvic exam and Pap testing; colposcopy with directed biopsy of the cervix shows atypical epithelial cells confined to the cervical epithelium consistent with carcinoma in situ of the cervix. The finding is stage-limited to the epithelium without stromal invasion, prompting surveillance or local treatment and assignment of a carcinoma in situ code for the cervix. Typical codes: D07.0
    • A postmenopausal patient reports a nonhealing ulcerative lesion on the vulva that has been present for months; biopsy demonstrates high-grade squamous carcinoma in situ (Bowen disease) of the vulva with no invasive component. The patient seeks evaluation for local excision or topical therapy, and the diagnosis of in situ neoplasm of the vulva is coded to capture the preinvasive lesion. Typical codes: D07.1
    • A patient with a history of abnormal vaginal bleeding undergoes examination and biopsy of a lesion on the vaginal wall; pathology reveals carcinoma in situ of the vagina confined to mucosa. The code for carcinoma in situ of the vagina is used to document the preinvasive tumor as a comorbidity affecting management decisions. Typical codes: D07.3, D07.39

    Related Codes

    D00-CARCINOMA-IN-SITU-ORAL-ESOPHAGUS-STOMACH

    ICD-10-CM Code For Carcinoma In Situ Of Oral Cavity, Esophagus And Stomach: Group Overview

    D01-CARCINOMA-IN-SITU-DIGESTIVE

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Digestive Organs: Group Overview

    D02-CARCINOMA-IN-SITU-MIDDLE-EAR-RESPIRATORY

    ICD-10-CM Code For Carcinoma In Situ Of Middle Ear And Respiratory System: Group Overview

    D03-MELANOMA-IN-SITU

    ICD-10-CM Code For Melanoma In Situ: Group Overview

    D04-CARCINOMA-IN-SITU-OF-SKIN

    ICD-10-CM Code For Carcinoma In Situ Of Skin: Group Overview

    D05-CARCINOMA-IN-SITU-OF-BREAST

    ICD-10-CM Code For Carcinoma In Situ Of Breast: Group Overview

    D06-CARCINOMA-IN-SITU-OF-CERVIX-UTERI

    ICD-10-CM Code For Carcinoma In Situ Of Cervix Uteri: Group Overview

    D09-CARCINOMA-IN-SITU-OTHER-UNSPECIFIED-SITES

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Sites: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.